{"name":"Centre Henri Becquerel","slug":"centre-henri-becquerel","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"F-Miso PET scan coupled with MRI","genericName":"F-Miso PET scan coupled with MRI","slug":"f-miso-pet-scan-coupled-with-mri","indication":"Detection and staging of various cancers, including lymphoma and melanoma","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"fentanyl transmucosal","genericName":"fentanyl transmucosal","slug":"fentanyl-transmucosal","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"F-Miso PET scan coupled with MRI","genericName":"F-Miso PET scan coupled with MRI","slug":"f-miso-pet-scan-coupled-with-mri","phase":"phase_2","mechanism":"F-Miso PET scan coupled with MRI is a diagnostic imaging technique that combines positron emission tomography (PET) and magnetic resonance imaging (MRI) to visualize and track the uptake of a radioactive tracer in the body.","indications":["Detection and staging of various cancers, including lymphoma and melanoma"],"catalyst":""},{"name":"fentanyl transmucosal","genericName":"fentanyl transmucosal","slug":"fentanyl-transmucosal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5sSWNnUWp1d2hmRFIwWjRuYkhSRTlDNlJNcGJhZGtrRDhnYW9vblBPWjR3QnV4UWdMazdDVWxiX1B3Wk5sWEhMdmpLTjdoamZmYklOWXZPTk1pM256QkNfODhFN1hQMDJCaTlXamVn0gFyQVVfeXFMTWg5anhjVmFFTkMxY3lER0NSZkdhd3JiREF5ZkZ1VVlITm51WTktd051T1JtaVJtS3JqSHQ3ZmRMQy1pVm5xSnRnT3VOSl8wTjkxRFNHMzRWS20wWHBMMTN1MFp1SVlKSHdpZVRacTZJdW1R?oc=5","date":"2021-12-15","type":"pipeline","source":"koreabiomed.com","summary":"Roche’s Polivy may change 1st-line standard of care for DLBCL in 20 years - koreabiomed.com","headline":"Roche’s Polivy may change 1st-line standard of care for DLBCL in 20 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOWWpfc2NMa1l3RkJaLWcya215ZEJXM2tDZ1IxRTQyTHp4c041UnFUUC1JNTUyOWlnWWJ5V3dqZFVzQXNLd1JUYlRxNlpXXzhaTDZBbktMYmhEajQtWnpMdW1nVms0NW1GNWIyTlpTRTJRY21vdHRfNW0wVkRxbkE3ZFZvR3ZPNGtxUk9CSTk0LWl5U1V0UTFhaGdkWQ?oc=5","date":"2014-05-06","type":"pipeline","source":"Hospital Pharmacy Europe","summary":"The role of the pharmacist in a multidisciplinary team - Hospital Pharmacy Europe","headline":"The role of the pharmacist in a multidisciplinary team","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}